call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Glycogen Storage Disorders Clinical Trials Market
Inquire Before Buying Request for Sample

Glycogen Storage Disorders Clinical Trials Market

Home Healthcare And Pharmaceutical Glycogen Storage Disorders Clinical Trials Market

Glycogen Storage Disorders (GSD) Clinical Trials Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2030, Segmented By Type (OTC, Rx Drugs); By Application (Hospital, Retail Pharmacy); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: January 2024
  • Report ID: BWC24048
  • Available Format: PDF
  • Page: 400

Report Overview

An increasing number of research and development programs aimed at treating glycogen storage disorders (GSD) and growing knowledge about rare illnesses are expected to boost the growth of Global Glycogen Storage Disorders (GSD) Clinical Trials Market during the forecast period between 2024 and 2030.

Global Glycogen Storage Disorders (GSD) Clinical Trials Market - Industry Trends & Forecast Report, 2030

The Global Glycogen Storage Disorders (GSD) Clinical Trials Market size is projected to grow at a CAGR of 12.02% during the forecast period between 2024 and 2030. Major growth factors for the Global Glycogen Storage Disorders (GSD) Clinical Trials Market include rising awareness of GSD among patients and medical professionals, technological advancements, and rising government and private investments in clinical trials for the development of their treatment methods. Furthermore, the Global Glycogen Storage Disorders (GSD) Clinical Trials Market is expected to witness significant growth opportunities, due to the development and approval of novel therapies for GSD.

Glycogen Storage Disorders (GSD) Clinical Trials – Overview

According to Johns Hopkins Medicine, “Glycogen storage disease (GSD) is a rare condition that changes the way the body uses and stores glycogen, a form of sugar or glucose.” It is a group of 19 hereditary diseases characterized by aberrant deposits or types of glycogens in tissues caused by a lack of one or more enzymes necessary for the synthesis or degradation of glycogen. GSD currently has no known treatment. Depending on the kind of GSD a person has, different treatments are used. The basic objective is to keep blood glucose levels within normal ranges so that cells have the energy they need to avoid long-term problems.

Global Glycogen Storage Disorders (GSD) Clinical Trials Market

Growth Drivers

Increasing Number of Glycogen Storage Disorders (GSD) Clinical Trials

With rising number of rare diseases and increased knowledge among medical professionals and patients, governments as well as private research institutes and pharmaceutical companies are extensively investing in research and development activities surrounding glycogen storage disorders (GSD), which is presenting lucrative growth opportunities to market players. For instance, Children’s Hospital of Orange Country, a pediatric acute care hospital in California, United States, conducts clinical trials for GSD type 1a for patients 8 years and older. Morderna, a biotechnology company, also announced clinical trial, known as Ba1ance Trial, of glycogen storage disease type 1a (GSD1a) treatment using mRNA-3745 for adults and pediatric patients.

Restraints

High Cost of Clinical Trials

Clinical trials for therapies to glycogen storage disorders are costly. For instance, clinical studies in phases 1, 2, and 3 across therapeutic categories cost about USD 4 million, USD 13 million, and USD 20 million, respectively, as Sofpromed notes. High cost of GSD clinical trials could be a major restraining factor for the growth of Global Glycogen Storage Disorders (GSD) Clinical Trials Market.

Impact of Escalating Geopolitical Tensions on Global Glycogen Storage Disorders (GSD) Clinical Trials Market

The escalating geopolitical tensions negatively affect the global glycogen storage disorders (GSD) clinical trials market. For instance, Ukraine has been a leading medical research country, having completed a total of 1,177 clinical trials in the decade before Russia’s invasion, as reported on Pharmaceutical Technology. However, the war completely disrupted the clinical trials sector in the country, including the Glycogen Storage Disorders (GSD) Clinical Trials Market. More than half of the clinical trials conducted in Ukraine are internationally funded and commercially sponsored. However, with the shift of investments toward humanitarian causes as well as the lack of resources and supply chain disruption in the medical research sector in Ukraine, the Glycogen Storage Disorders (GSD) Clinical Trials Market has suffered significant losses.

Global Glycogen Storage Disorders (GSD) Clinical Trials Market

Segmental Coverage

Global Glycogen Storage Disorders (GSD) Clinical Trials Market – By Type

Based on type, the Global Glycogen Storage Disorders (GSD) Clinical Trials Market is segmented into OTC and Rx drugs. The OTC drugs segment holds a larger share in the (GSD) Clinical Trials Market. Glycogen storage disorder has no known cure; hence, symptom management is the primary method of treatment, as the Cleveland Clinic opines. The OTC segment offers medications to treat common symptoms of glycogen storage disorders, including low blood sugar, high cholesterol, and uric acid levels, all of which support the segment's expansion.

Global Glycogen Storage Disorders (GSD) Clinical Trials Market – By Application

Based on application, the Global Glycogen Storage Disorders (GSD) Clinical Trials Market is split into hospital and retail pharmacy segments. The hospital segment accounts for a higher share of the market. Clinical trials are essential to raising the standard of healthcare. People frequently volunteer to participate in these studies to evaluate the effectiveness and safety of novel medical therapies.

Glycogen Storage Disorders (GSD) Clinical Trials Market

Global Glycogen Storage Disorders (GSD) Clinical Trials Market – By Region

The in-depth research report on the Global Glycogen Storage Disorders (GSD) Clinical Trials Market covers the market in a number of major countries across five regions: North America, Europe, Asia Pacific (APAC), Latin America, the Middle East and Africa. North America dominates the Global Glycogen Storage Disorders (GSD) Clinical Trials Market. The United States ranks highest in the academic field of clinical medicine owing to the high concentration of pharmaceutical companies and renowned research institutions and therefore attracts significant investment in research and development activities in medical research.

Glycogen Storage Disorders Clinical Trials Market Share

Competitive Landscape

Major players operating in the Global Glycogen Storage Disorders (GSD) Clinical Trials Market include Merck, Sanofi, Nestlé Health Science, Mayo Clinical Laboratories, Reneo Pharmaceuticals, CHOC, Duke Health, and Ultragenyx. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In May 2023 – Maze Therapeutics, a biotechnology company based in the United States, signed an exclusive worldwide license agreement with Sanofi, a multinational pharmaceutical and healthcare company based in France, for MZE001, an oral substrate reduction therapy for the treatment of Pompe disease.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2023

Base Year – 2023

Estimated Year – 2024

Forecast Period– 2024–2030

Facts Covered

Revenue in USD Billion

Market Coverage

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Product/ Service Segmentation

Type, Application, Region

Key Players

Merck, Sanofi, Nestlé Health Science, Mayo Clinical Laboratories, Reneo Pharmaceuticals, CHOC, Duke Health, Ultragenyx

 

By Type

  • OTC

  • Rx Drugs

By Application

  • Hospital

  • Retail Pharmacy

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America (LATAM)

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. Type Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Glycogen Storage Disorders (GSD) Clinical Trials Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Growing Awareness among Healthcare Professionals, Patients, and Advocacy Groups About Rare Diseases
        2. Rising Number of Research and Development Activities for the Treatment of Glycogen Storage Disorders (GSD)
      2. Restraints
        1. High Development Costs
        2. Limited Patient Pool
      3. Opportunities
        1. Development of Novel Therapies
        2. Expanding Clinical Trials to Diverse Geographic Regions
      4. Challenges
        1. Lack of Awareness about ISOBUS Technology and equipment Manufacturers
    3. Technological Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Glycogen Storage Disorders (GSD) Clinical Trials Market Overview
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
        1. OTC
        2. Rx Drugs
      2. By Application
        1. Hospital
        2. Retail Pharmacy
      3. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Glycogen Storage Disorders (GSD) Clinical Trials Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Application
      3. By Country
        1. United States
          1. By Type
          2. By Application
        2. Canada
          1. By Type
          2. By Application
  6. Europe Glycogen Storage Disorders (GSD) Clinical Trials Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Application
      3. By Country
        1. Germany
          1. By Type
          2. By Application
        2. United Kingdom
          1. By Type
          2. By Application
        3. Italy
          1. By Type
          2. By Application
        4. France
          1. By Type
          2. By Application
        5. Spain
          1. By Type
          2. By Application
        6. Belgium
          1. By Type
          2. By Application
        7. Russia
          1. By Type
          2. By Application
          3.  
        8. The Netherlands
          1. By Type
          2. By Application
        9. Rest of Europe
          1. By Type
          2. By Application
  7. Asia Pacific Glycogen Storage Disorders (GSD) Clinical Trials Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Application
      3. By Country
        1. China
          1. By Type
          2. By Application
        2. India
          1. By Type
          2. By Application
        3. Japan
          1. By Type
          2. By Application
        4. South Korea
          1. By Type
          2. By Application
        5. Australia & New Zealand
          1. By Type
          2. By Application
        6. Indonesia
          1. By Type
          2. By Application
        7. Malaysia
          1. By Type
          2. By Application
        8. Singapore
          1. By Type
          2. By Application
        9. Vietnam
          1. By Type
          2. By Application
        10. Rest of APAC
          1. By Type
          2. By Application
  8. Latin America Glycogen Storage Disorders (GSD) Clinical Trials Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Application
      3. By Country
        1. Brazil
          1. By Type
          2. By Application
        2. Mexico
          1. By Type
          2. By Application
        3. Argentina
          1. By Type
          2. By Application
        4. Peru
          1. By Type
          2. By Application
        5. Rest of LATAM
          1. By Type
          2. By Application
  9. Middle East and Africa Glycogen Storage Disorders (GSD) Clinical Trials Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Application
      3. By Country
        1. Saudi Arabia
          1. By Type
          2. By Application
        2. UAE
          1. By Type
          2. By Application
        3. Qatar
          1. By Type
          2. By Application
        4. Kuwait
          1. By Type
          2. By Application
        5. South Africa
          1. By Type
          2. By Application
        6. Nigeria
          1. By Type
          2. By Application
        7. Algeria
          1. By Type
          2. By Application
        8. Rest of MEA
          1. By Type
          2. By Application
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Glycogen Storage Disorders (GSD) Clinical Trials Company Market Share Analysis, 2023
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Escalating Geopolitical Tensions on Global Glycogen Storage Disorders (GSD) Clinical Trials Market
  12. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Merck
    2. Sanofi
    3. Nestlé Health Science
    4. Mayo clinical laboratories
    5. Reneo Pharmaceuticals
    6. CHOC
    7. Duke health
    8. Ultragenyx
    9. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1. Qualitative Research
      1. Primary & Secondary Research
    2. Quantitative Research
    3.  Market Breakdown & Data Triangulation
      1.  Secondary Research˙
      2.  Primary Research
    4.  Breakdown of Primary Research Respondents, By Region
    5.  Assumptions & Limitations

 

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

 

List of Figures

 

Figure 1       Global Glycogen Storage Disorders (GSD) Clinical Trials Segmentation

Figure 2       Global Glycogen Storage Disorders (GSD) Clinical Trials Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2023

Figure 4       Global Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 5       Global Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 6       Global Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 7       Global Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Region, By Value, 2019–2030

Figure 8       North America Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 9       North America Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 10     North America Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 11     North America Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Country, By Value, 2019–2030

Figure 12     United States Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 13     United States Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 14     United States Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 15     Canada Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 16     Canada Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 17     Canada Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 18     Europe Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 19     Europe Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 20     Europe Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 21     Europe Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Country, By Value, 2019–2030

Figure 22     Germany Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 23     Germany Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 24     Germany Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 25     United Kingdom Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 26     United Kingdom Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 27     United Kingdom Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 28     Italy Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 29     Italy Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 30     Italy Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 31     France Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 32     France Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 33     France Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 34     Spain Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 35     Spain Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 36     Spain Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 37     Belgium Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 38     Belgium Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 39     Belgium Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 40     Russia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 41     Russia Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 42     Russia Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 43     The Netherlands Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 44     The Netherlands Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 45     The Netherlands Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 46     Rest of Europe Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 47     Rest of Europe Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 48     Rest of Europe Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 49     Asia Pacific Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 50     Asia Pacific Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 51     Asia Pacific Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 52     Asia Pacific Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Country, By Value, 2019–2030

Figure 53     China Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 54     China Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 55     China Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 56     India Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 57     India Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 58     India Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 59     Japan Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 60     Japan Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 61     Japan Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 62     South Korea Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 63     South Korea Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 64     South Korea Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 65     Australia & New Zealand Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 66     Australia & New Zealand Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 67     Australia & New Zealand Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 68     Indonesia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 69     Indonesia Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 70     Indonesia Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 71     Malaysia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 72     Malaysia Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 73     Malaysia Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 74     Singapore Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 75     Singapore Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 76     Singapore Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 77     Vietnam Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 78     Vietnam Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 79     Vietnam Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 80     Rest of APAC Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 81     Rest of APAC Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 82     Rest of APAC Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 83     Latin America Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 84     Latin America Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 85     Latin America Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 86     Latin America Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Country, By Value, 2019–2030

Figure 87     Brazil Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 88     Brazil Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 89     Brazil Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 90     Mexico Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 91     Mexico Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 92     Mexico Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 93     Argentina Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 94     Argentina Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 95     Argentina Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 96     Peru Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 97     Peru Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 98     Peru Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 99     Rest of LATAM Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 100   Rest of LATAM Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 101   Rest of LATAM Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 102   Middle East and Africa Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 103   Middle East and Africa Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 104   Middle East and Africa Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 105   Middle East and Africa Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Country, By Value, 2019–2030

Figure 106   Saudi Arabia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 107   Saudi Arabia Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 108   Saudi Arabia Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 109   UAE Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 110   UAE Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 111   UAE Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 112   Qatar Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 113   Qatar Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 114   Qatar Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 115   Kuwait Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 116   Kuwait Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 117   Kuwait Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 118   South Africa Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 119   South Africa Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 120   South Africa Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 121   Nigeria Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 122   Nigeria Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 123   Nigeria Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 124   Algeria Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 125   Algeria Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 126   Algeria Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

Figure 127   Rest of MEA Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Figure 128   Rest of MEA Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Type, By Value, 2019–2030

Figure 129   Rest of MEA Glycogen Storage Disorders (GSD) Clinical Trials Market Share, By Application, By Value, 2019–2030

 

List of Tables

 

Table 1        Global Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 2        Global Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 3        Global Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 4        Global Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Region, By Value, 2019–2030

Table 5        North America Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 6        North America Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 7        North America Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 8        North America Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Country, By Value, 2019–2030

Table 9        United States Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 10      United States Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 11      United States Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 12      Canada Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 13      Canada Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 14      Canada Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 15      Europe Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 16      Europe Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 17      Europe Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 18      Europe Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Country, By Value, 2019–2030

Table 19      Germany Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 20      Germany Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 21      Germany Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 22      United Kingdom Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 23      United Kingdom Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 24      United Kingdom Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 25      Italy Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 26      Italy Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 27      Italy Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 28      France Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 29      France Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 30      France Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 31      Spain Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 32      Spain Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 33      Spain Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 34      Belgium Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 35      Belgium Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 36      Belgium Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 37      Russia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 38      Russia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 39      Russia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 40      The Netherlands Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 41      The Netherlands Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 42      The Netherlands Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 43      Rest of Europe Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 44      Rest of Europe Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 45      Rest of Europe Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 46      Asia Pacific Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 47      Asia Pacific Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 48      Asia Pacific Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 49      Asia Pacific Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Country, By Value, 2019–2030

Table 50      China Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 51      China Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 52      China Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 53      India Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 54      India Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 55      India Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 56      Japan Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 57      Japan Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 58      Japan Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 59      South Korea Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 60      South Korea Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 61      South Korea Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 62      Australia & New Zealand Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 63      Australia & New Zealand Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 64      Australia & New Zealand Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 65      Indonesia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 66      Indonesia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 67      Indonesia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 68      Malaysia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 69      Malaysia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 70      Malaysia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 71      Singapore Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 72      Singapore Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 73      Singapore Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 74      Vietnam Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 75      Vietnam Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 76      Vietnam Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 77      Rest of APAC Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 78      Rest of APAC Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 79      Rest of APAC Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 80      Latin America Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 81      Latin America Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 82      Latin America Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 83      Latin America Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Country, By Value, 2019–2030

Table 84      Brazil Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 85      Brazil Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 86      Brazil Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 87      Mexico Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 88      Mexico Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 89      Mexico Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 90      Argentina Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 91      Argentina Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 92      Argentina Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 93      Peru Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 94      Peru Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 95      Peru Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 96      Rest of LATAM Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 97      Rest of LATAM Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 98      Rest of LATAM Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 99      Middle East and Africa Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 100    Middle East and Africa Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 101    Middle East and Africa Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 102    Middle East and Africa Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Country, By Value, 2019–2030

Table 103    Saudi Arabia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 104    Saudi Arabia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 105    Saudi Arabia Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 106    UAE Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 107    UAE Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 108    UAE Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 109    Qatar Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 110    Qatar Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 111    Qatar Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 112    Kuwait Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 113    Kuwait Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 114    Kuwait Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 115    South Africa Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 116    South Africa Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 117    South Africa Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 118    Nigeria Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 119    Nigeria Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 120    Nigeria Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 121    Algeria Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 122    Algeria Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 123    Algeria Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 124    Rest of MEA Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Value (USD Billion), 2019–2030

Table 125    Rest of MEA Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Type, By Value, 2019–2030

Table 126    Rest of MEA Glycogen Storage Disorders (GSD) Clinical Trials Market Size, By Application, By Value, 2019–2030

Table 127    Merck Company Overview

Table 128    Merck Financial Overview

Table 129    Sanofi Company Overview

Table 130    Sanofi Financial Overview

Table 131    Nestlé Health Science Company Overview

Table 132    Nestlé Health Science Financial Overview

Table 133    Mayo Clinical Laboratories Company Overview

Table 134    Mayo Clinical Laboratories Financial Overview

Table 135    Reneo Pharmaceuticals Company Overview

Table 136    Reneo Pharmaceuticals Financial Overview

Table 137    CHOC Company Overview

Table 138    CHOC Financial Overview

Table 139    Duke health Company Overview

Table 140    Duke health Financial Overview

Table 141    Ultragenyx Company Overview

Table 142    Ultragenyx Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Note: Please share the corporate email address for faster response

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Global Glycogen Storage Disorders (GSD) Clinical Trials Market size is expected to grow at a CAGR of 12.02% during the forecast period between 2024 and 2030.
Ans: Major factors driving the growth of the Global Glycogen Storage Disorders (GSD) Clinical Trials Market include an increase in the amount of research and development initiatives aimed at treating glycogen storage disorders, as well as increased knowledge of rare illnesses among patients, advocates, and medical professionals.
Ans: Key players in the Global Glycogen Storage Disorders (GSD) Clinical Trials Market include Merck, Sanofi, Nestlé Health Science, Mayo Clinical Laboratories, Reneo Pharmaceuticals, CHOC, Duke Health, and Ultragenyx.
Ans: The OTC segment holds a higher market share in the Global Glycogen Storage Disorders (GSD) Clinical Trials Market by type.
Ans: The hospital segment is expected to grow at a higher CAGR in the Global Graphite Market during the forecast period between 2024 and 2030.
Ans: Asia Pacific is expected to grow at the fastest rate in the Global Glycogen Storage Disorders (GSD) Clinical Trials Market during the forecast period between 2024 and 2030. 
array(1) {
  ["__ci_last_regenerate"]=>
  int(1734909265)
}